EUVIMEDEUVIMED entdecken
Crossref

2.人工核酸を用いた遺伝子標的核酸医薬の開発

陽祐 谷口

Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics · 2026 · 57 (3) · 37-40

DOI: 10.3999/jscpt.57.3_37 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 2026. Verfasst von 陽祐 谷口.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

谷口, 陽. (2026). 2.人工核酸を用いた遺伝子標的核酸医薬の開発. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 57(3), 37-40. https://doi.org/10.3999/jscpt.57.3_37

Vancouver

谷口 陽. 2.人工核酸を用いた遺伝子標的核酸医薬の開発. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 2026;57(3):37-40. doi:10.3999/jscpt.57.3_37

BibTeX
@article{2026,
  author = {谷口, 陽祐},
  title = {2.人工核酸を用いた遺伝子標的核酸医薬の開発},
  journal = {Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics},
  year = {2026},
  volume = {57},
  number = {3},
  pages = {37--40},
  doi = {10.3999/jscpt.57.3_37}
}
Kostenlos starten →